Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Join | Sign in
Home>Videos>This Video
  Videos

Return

Chemical Biology Approaches to Target Protein Modification in Disease
Imperial College London

My group works in the emerging multidisciplinary field of chemical proteomics, where we design and apply chemistry-driven approaches to explore posttranslational modification (PTM) in living systems. A constant theme in our work is the validation of enzymes involved in PTM as drug targets and discovery of novel drug-like enzyme inhibitors, using tools ranging from protein total synthesis and labelling to activity-based protein profiling and proteomics. Recent technological advances based on bioorthogonal ligation chemistry have enabled several classes of PTM, including protein lipidation, to be probed with greatly enhanced speed and flexibility, and are rapidly supplanting older approaches such as radiolabelling. In this presentation I will highlight some of our recent advances in probing protein lipidation using chemical proteomics, and describe how we have applied this technology to understand and exploit novel drug targets in protein lipidation pathways in parasitic infection and cancer.

Request more information
Company product page


Access to this article and other content is for registered users.

Join the Technology Networks Community

  • Access to the latest scientific news, products and research through Technology Networks
  • Upload and share your posters on ePosters
  • View a library of 1,800+ scientific and medical posters
  • A library of 3,000+ scientific videos on LabTube


Sign In



Forgotten your details? Click Here
If you already have an account with Technology Networks, please use your existing login details. If you do not yet have an account please join here.

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Starting Antiretroviral Treatment Early Improves Outcomes for HIV-infected Individuals
NIH-funded trial results likely will impact global treatment guidelines.
Scientists are Designing Decoy Drugs to Fool Cancer
Study shows potential of drugs that can target the Notch switch with reduced toxicity.
Viral Immunotherapy For Skin Cancer Shows Patient Benefit
A genetically engineered herpes virus can halt the progression of skin cancer by killing cancer cells and sparking the immune system into action against tumours, a landmark clinical trial has shown.
Seeing the Action
Researchers have developed a way to observe both the forces present and the behavior that occurs during cell hemifusion; the merging of the lipid bi-layers of two cells.
Non-Aqueous Solvent Supports DNA Nanotech
Researchers at the Georgia Institute of Technology have now shown that they can assemble DNA nano-structures in a solvent containing no water.
‘Rosetta Stone’ for Prostate Cancer Mutations
Scientists have produced a comprehensive genetic map of the mutations in prostate cancer that have spread across the body.
From Worker to Queen at the Drop of a Gene
Biologists have found that the hierarchical fate of one of nature's most important pollinators comes down to which genes are "turned on or off".
First Step Towards Global Attack on Potato Blight
European researchers and companies concerned with the potato disease phytophthora will work more closely with parties in other parts of the world.
Bioresorbable Electronic Stent Could Provide Feedback, Therapy
Researchers have developed and tested a drug releasing electronic stent which could significantly reduce the risk associated with traditional mesh tube stents.
Tiny Heart, Big Promise
Researchers have discovered a new source of cells that can develop into coronary vessels.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters